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Abstract
Background: There is a danger that mass drug administration campaigns may fail to maintain adequate
treatment coverage to achieve lymphatic filariasis elimination. Hence, additional measures to suppress
transmission might be needed to ensure the success of the Global Program for the Elimination of
Lymphatic Filariasis.
Discussion: Vector control successfully eliminated lymphatic filariasis when implemented alone or with
mass drug administration. Challenges to lymphatic filariasis elimination include uncertainty of the exact
level and duration of microfilarial suppression required for elimination, the mobility of infected individuals,
consistent non-participation of some infected individuals with mass drug administration, the possible
development of anti-filarial drug resistance and treatment strategies in areas co-endemic with loasis.
Integration of vector control with mass drug administration can address some of these challenges. The
potential benefits of vector control would include: (1) the ability to suppress filariasis transmission without
the need to identify all individual 'foci of infection'; (2) minimizing the risk of reestablishment of
transmission from imported microfilaria positive individuals; and (3) decreasing the risk of dengue or
malaria transmission where, respectively, Aedes or Anopheles are lymphatic filariasis vectors.
Summary: With adequate sustained treatment coverage, mass drug administration should meet the
criteria for elimination of lymphatic filariasis. However, it may be difficult to sustain sufficiently high mass
drug administration coverage to achieve lymphatic filariasis elimination in some areas, particularly, where
Aedes species are the vectors. Since vector control was effective in controlling and even eliminating
lymphatic filariasis transmission, integration of vector control with mass drug administration will ensure
the sustainability of transmission suppression and thereby better ensure the success of national filariasis
elimination programs. Although trials of some vector control interventions are needed, proven vector
control strategies are ready for immediate integration with mass drug administration for many important
vectors. Vector control is the only presently available additional lymphatic filariasis control measure with
the potential for immediate implementation.
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Background
Efforts to control lymphatic filariasis (LF) have a long his-
tory in the Pacific island countries and territories.
Although only Wuchereria bancrofti is found in the South
Pacific, the epidemiology of transmission is complex. In
Micronesia and in the Melanesian countries of Papua New
Guinea (PNG) and Vanuatu, the parasite is periodic.
Transmission is by Culex quinquefasciatus in Micronesia,
while the members of the Anopheles punctulatus complex
transmit both malaria and Wuchereria bancrofti in PNG
and Vanuatu. In New Caledonia, W. bancrofti is aperiodic
and transmitted by the night and day-time biting Aedes
vigilax. Where W. bancrofti is subperiodic, it may be trans-
mitted by various Aedes vectors (Table 1). From Fiji to
French Polynesia, 15 Aedes vectors are reported (six vec-
tors are found in Fiji alone). Except for Ae. polynesiensis
and Ae. vigilax, little is known about the ecology of these
mosquitoes. Ae. polynesiensis is arguably the most impor-
tant LF vector in the Pacific, in part because it exhibits a
characteristic known as 'limitation', whereby the percent-
age of microfilaria (mf) which develop to stage 3 larvae
increases with decreasing densities of mf [1]. For this rea-
son, Ae polynesiensis may pose the greatest challenge to LF
elimination in the region.
The Pacific Programme for the Elimination of Lymphatic
Filariasis (PacELF) was the first regional LF elimination
programme established [2]. Following the Global Lym-
phatic Filariasis Elimination Programme recommenda-
tions for stopping transmission, PacELF has targeted
>80% of populations in endemic areas with diethylcar-
bamazine (DEC) and albendazole annually for at least
five years. Evidence that the DEC/albendazole combina-
tion will be more successful than monotherapy with DEC
against adult worms is supported by reductions in both
adult worm antigen levels and in clinical reactions in
infected humans receiving the drug combination [3]. This
combination therapy appears to be more effective in
reducing the prevalence and density of mf for longer time
periods than DEC alone [4].
Under PacELF, national MDAs were undertaken in the fol-
lowing countries where Aedes species are important vec-
tors of W. bancrofti: American Samoa, Cook Islands, Fiji,
French Polynesia, Niue, Samoa, Tonga, Tuvalu, and Wallis
and Futuna (Tokelau is no longer considered to be
endemic). By the end of 2005, five or more rounds of
MDA had been completed in the Cook Islands, French
Polynesia, Niue, Samoa and Tonga. Samoa is the only
country to have completed its prevalence assessment after
five rounds of MDA, with annual coverage ranging from
57% to 90%. In addition to these programmes where
Aedes transmit filaria, MDA has been undertaken in coun-
tries where Anopheles (Vanuatu and Papua New Guinea)
and Cx quinquefasciatus (Federated States of Micronesia,
Kiribati, Marshall Islands and Palau) are the primary vec-
tors.
Previous MDA based campaigns using only DEC in
Samoa and French Polynesia suggest that caution should
be exercised on deciding when to stop MDA. These cam-
paigns often succeeded in achieving significant reductions
in mf rates and intensities and LF associated morbidity [5-
7]. In Samoa, five extensive campaigns using DEC, includ-
ing 12–18 month treatments in 1966 and 1971, and sin-
gle annual doses in 1982, 1983 and 1986, reduced the mf
rate from 21% in 1964 to 2.3% in 1987 (Figure 1). Mf
rates declined to 0.14% in 1974, following the second
DEC campaign, but rebounded to 2.1% within two years
[5].
Table 1: Reported Aedes vectors of lymphatic filariasis in the Pacific
Vector Countries where found
Aedes cooki Niue
Aedes fijiensis Fiji
Aedes horrensces Fiji
Aedes kochi Papua New Guinea
Aedes marshallensis Kiribati
Aedes oceanicus Tonga, Samoa
Aedes polynesiensis American Samoa, Samoa, Cook Islands, Tokelau, Tuvalu, French Polynesia, Wallis and Futuna, Fiji
Aedes pseudoscutellaris Fiji
Aedes rotumae Rotuma Island in Fiji
Aedes samoanus Samoa
Aedes tabu Tonga
Aedes tongae Tonga
Aedes tutuilae Samoa
Aedes upolenis Samoa
Aedes vigilax New Caledonia, FijiFilaria Journal 2006, 5:10 http://www.filariajournal.com/content/5/1/10
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In French Polynesia, twice yearly DEC chemotherapy (6
mg/kg) was administered for 34 years beginning in 1955
to an average of 85% of the population on Maupiti island
(excluding the years 1960–67 and 1970–74) [6]. In addi-
tion, mosquito control using DDT (1955–1957) and lar-
val source reduction (1955–1970) was implemented.
Despite these efforts, a comprehensive survey in 2000
found that 0.4% of residents still had circulating mf and
4.6% had antigenaemia [6].
After cessation of the MDA campaigns in Samoa and
French Polynesia, mf rates increased [5,8]. While these
extensive campaigns succeeded in reducing filariasis trans-
mission, elimination of the parasite was not achieved. Mf
resurgence was attributed to poor compliance, inadequate
campaign durations and failure of DEC to completely kill
or sterilize adult W. bancrofti in treated people (Chow CY:
Filariasis vectors and their control in the South Pacific. In
4th Joint WHO/SPC seminar on Filariasis and Vector Control.
Apia, W. Samoa, WPR/Fil/9. Manila, World Health Organ-
ization, 1974). A subsequent analysis of LF positive indi-
viduals on Maupiti suggested that continued transmission
can be attributed to individuals who persistently failed to
participate in the MDA programme (Nguyen, personal
communication).
The historic MDA campaigns in Samoa and French Poly-
nesia, described above, relied on DEC alone. The present
GPELF (outside Africa) and PacELF strategies rely on the
treatment combination of DEC with albendazole that is
reportedly more effective against W. bancrofti. However,
recent systematic reviews question whether there really is
an improved effectiveness of DEC and albendazole com-
pared to DEC alone. These analyses suggest that the addi-
tion of albendazole to DEC does not significantly
improve the microfilaricidal [9,10] or macrofilariacidal
activity of DEC [9]. These disconcerting conclusions were
based on a limited number of studies. A more recent study
found significantly greater reductions in microfilaemia
intensity and antigenaemia prevalence in persons treated
with DEC and albendazole compared to DEC alone [11].
Additional studies are clearly needed. There can be little
doubt that administration of albendazole with DEC ben-
efits the people receiving the drugs. However, concerns
remain about the ability of MDA alone to succeed in elim-
inating LF without ongoing universal coverage of the eli-
gible target populations, particularly in areas where
efficient vectors such as Ae. polynesiensis exist. Hence, there
is a need to consider complementary control strategies to
ensure the success of the global LF elimination campaign.
The only presently available alternative to filaricidal treat-
ments (MDA-based campaigns or distribution of DEC-
medicated salt) is vector control.
Vector control was the primary tool for controlling filaria-
sis in the Pacific before effective antifilarial drugs were
available and even after effective antifilarials became
available vector control was preferred by Pacific island
ministries and departments of health because MDA cam-
paigns were considered too labour intensive [12].
Elimination of filariasis using vector control alone has
already been successfully documented in the Pacific.
Where Anopheles species are the vectors of malaria and
filariasis, filariasis was eliminated from areas where
indoor residual spraying (IRS) with DDT to control
malaria was undertaken in areas of Papua New Guinea
[13] and throughout the Solomon Islands [14,15].
W. bancrofti was also eliminated from Australia by sanita-
tion campaigns that controlled the major vector, Cx quin-
quefasciatus [16]. Vector control also played a significant
role in elimination of LF from Japan [17]. Demonstration
of the impact of polystyrene beads on Cx quinquefasciatus
populations and hence on LF transmission in Zanzibar
and India where pit latrines or soakage pits are major
breeding sites suggests that control of Cx quinquefasciatus
can augment MDA to suppress transmission [18-20].
Aedes polynesiensis has been successfully controlled in a
small number of trials of limited scope in the Pacific
(Table 2). Mesocyclops aspericornis reduced the number of
Ae. polynesiensis larvae in treated crab holes by 98% [21].
The effectiveness of larval source-reduction campaigns
against Ae. polynesiensis has been repeatedly demonstrated
in French Polynesia [22] (Kessel JF: Combined control meth-
Impact of DEC on microfilaria prevalence rates in Samoa:  1964–1994 Figure 1
Impact of DEC on microfilaria prevalence rates in 
Samoa: 1964–1994. DEC-based MDAs were administered 
at either 5 or 6 mg/kg body weight as either a single annual 
dose or monthly for 12 or 18 months, as indicated. Ivermec-
tin (+Iv) was administered in 1996 and 1997 at a dose of 200 
μg/kg body weight with a single dose of DEC at 6 mg/kg body 
weight [5].Filaria Journal 2006, 5:10 http://www.filariajournal.com/content/5/1/10
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ods in filariasis. Manila, World Hlth Org, unpublished
report, 1965 (FIL/WP/16.65), particularly when inte-
grated with other measures [23] including removal of veg-
etation to facilitate discovery of breeding sites (Byrd EE, St
Amant LS: Studies on the epidemiology of filariasis on
Central and South Pacific Islands. In SPC Technical Paper,
1959, 125:52–55) and MDA campaigns [24]. Such cam-
paigns can be effective even though they are labour inten-
sive (Hairston N: Assessment of filariasis in Western Samoa.
Assignment report. Manila, World Hlth Org 1973) and
despite the rapidity with which breeding sites reappear
after campaigns are concluded [25].
However, not all vector control interventions are success-
ful. Insecticide fogging campaigns had minimal impacts
on Ae. polynesiensis biting rates, with reductions of less
than 64% reported in three unpublished trials (Suzuki T,
Stone F: Laboratory and field tests of insecticides against vector
mosquitos of subperiodic filariasis in Western Samoa. Unpub-
lished report to WHO, 1976; Chow CY: Filariasis vectors
and their control in the South Pacific. In 4th Joint WHO/
SPC seminar on Filariasis and Vector Control. Apia, W.
Samoa, WPR/Fil/9. Manila, World Health Organization,
1974; Wharton JD, Jachowski LA. In: Zahar, King and
Chow. A review and annotated bibliography on subperiodic
bancroftian filariasis with special reference to its vectors in
Polynesia, South Pacific. Manila, World Health Organiza-
tion, 1980). There have not been any studies on control-
ling the salt marsh breeding Ae. vigilax in the Pacific
islands. While runnels (ditches designed to allow tidal
flushing of salt marshes) have decreased larval numbers in
Australia [26], the impact of runnels on Ae. vigilax biting
rates needs to be evaluated before widespread program-
matic application can be considered.
Discussion
Despite significant progress towards LF elimination, a
number of challenges to MDA-based LF elimination pro-
grammes remain. Firstly, we do not know the exact level
and duration of mf suppression required for elimination
to be achieved. A target goal reduction of mf prevalence
below 1% for transmission elimination may not be an
appropriate target where Aedes mosquitoes are vectors. In
Samoa, mf rates were less than 0.33% between 1972 and
1974, but LF prevalence rates rose soon after MDA was
stopped. It is likely that foci of mf positive individuals
capable of initiating resurgence of LF will remain after five
or more MDAs with DEC and albendazole. Five years of
MDA with DEC and albendazole in Egypt do not appear
to have been sufficient to eliminate LF transmission in
areas that had high baseline infection rates [27]. Effective
tools for locating such foci in countries with a low overall
residual mf prevalence after five or more annual MDAs
have yet to be developed.
A second significant challenge in the Pacific is population
mobility. Migration is particularly common in many of
the Pacific islands; more Cook Islanders live in New Zea-
Table 2: Summary of field trials for controlling Aedes in the Pacific
Vector* Breeding site Country Control method % Reduction in 
Mosquitoes
Reference
Ae. polynesiensis Crab holes Fiji 1% Lindane and 
plugging of crab holes
0% on biting 26
Ae. polynesiensis All types French Polynesia Breeding site 
elimination within 100 
yd. of village
80% to 90% Kessel JF, 1965, 
unpublished
Ae. polynesiensis All types French Polynesia Breeding site 
elimination; vegetation 
control
81% of biting Adults Byrd EE, St Amant LS, 
1959, unpublished
Ae. polynesiensis and 
Ae. samoanus
All types Samoa DDT spray of 
breeding site and 
fogging of houses/bush
64% of biting adults Suzuki, Stone, 1976, 
unpublished
Ae. polynesiensis and 
Ae. samoanus
Not reported Samoa Abate larvicide and 
malathion fog
60% of biting adults Chow CY, 1974, 
unpublished
Ae. polynesiensis Not reported American Samoa DDT house spraying; 
aerial spraying every 
14 days
0% of adults after 14 
days
Wharton JD, 
Jachowski LA, 1980, 
unpublished
Ae. aegypti and Ae. 
polynesiensis
Cisterns, wells, drums French Polynesia Integrated control 
(Abate, sealing drums, 
polystyrene beads, 
Poecillia reticulata)
84% of adults 23
Ae. polynesiensis Crab holes French Polynesia Mesocyclops 
aspericornis
98% of larvae 21
Ae. polynesiensis Crab holes French Polynesia Insecticide 
impregnated crab bait
86% of larvae 39Filaria Journal 2006, 5:10 http://www.filariajournal.com/content/5/1/10
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land than on the main island of Rarotonga. Samoans fre-
quently travel between Samoa and American Samoa for
economic opportunities and to visit relatives and friends
living in the neighbouring country. A significant propor-
tion of internal migrants in Papua New Guinea are mf
positive [28]. Such migrants are likely to miss annual
MDA treatments, thereby raising the possibility of reintro-
duction of LF.
A third challenge is the presence of individuals whose
occupational or social behaviour places them at risk of
infection or who consistently fail to participate in MDA,
placing their communities at risk of ongoing transmission
[29,30]. Merely increasing the number of years of MDA
campaigns will not reach these individuals. A better
understanding of their perceptions and priorities will
allow tailoring of elimination messages and interventions
so that they are locally appropriate and acceptable [31].
A fourth challenge is the potential for W. bancrofti to
develop resistance to either DEC or albendazole. Albenda-
zole resistance is already common amongst helminths of
veterinary importance. Although there is currently no evi-
dence of resistance to DEC or albendazole in areas where
LF elimination programmes are under way, no reliable
assay system is currently available to allow assessment of
resistance in filarial nematodes. Resistance is more likely
to appear in an MDA programme after several rounds of
treatment when success appears to be in sight.
A fifth challenge is areas where LF and loiasis are co-
endemic [30]. MDA cannot be implemented in these areas
until mf densities are reduced to levels where significant
adverse reactions from MDA will not occur. This is due to
severe adverse events associated with treatment with Mec-
tizan® (ivermectin) in community directed treatment in
onchocerciasis if patients have high microfilarial loads of
Loa loa.
These challenges can be met by integrating vector control
with MDA for LF elimination [32]. Vector control is the
only presently available adjunct LF control measure with
the potential for immediate implementation. Although
treatment with doxycycline has been shown to eliminate
mf and to have macrofilaridal activity, mass treatment is
not practical due to the logistic difficulties of delivering
daily doxycycline treatments of 200 mg for 6 to 8 weeks
[33]. In addition, doxycycline is also contraindicated for
use in children under 8 years and in pregnant women.
National scale vector control programmes would have
multiple potential benefits for LF elimination pro-
grammes. These include (1) the ability to suppress LF
transmission without the need to identify all individual
'foci of infection'; (2) minimizing the risk of reestablish-
ment of transmission from imported mf positive individ-
uals; and (3) reducing the spread of any DEC or
albendazole resistant W. bancrofti which might emerge.
Furthermore, control measures targeting vectors will also
decrease the risk of dengue or malaria transmission
where, respectively,Aedes or Anopheles are the LF vectors.
The reduction of nuisance in addition to vector mosquito
biting is likely to enhance community support for ELF
programmes. Implementation of vector control strategies
as adjuncts to the MDA campaigns will better ensure the
success of the elimination efforts and enhance the pros-
pects for sustainable benefit.
Mosquito surveillance and control as adjuncts to MDA are
already included in many country filariasis elimination
plans even though they may not be actively implemented.
Among PacELF countries, activities commonly mentioned
include larval surveys for filariasis vectors, environmental
sanitation to reduce mosquito breeding sites, use of mos-
quito nets and ultra-low-volume (ULV) spraying against
adult mosquitoes. We need to support vector control
efforts to ensure that the limited resources available to
ministries of health are spent effectively. There are a
number of vector control strategies whose efficacy against
transmission of LF has been demonstrated. These include
the use of insecticide treated mosquito nets where Anoph-
eles are LF vectors [34,35] and the use of polystyrene beads
for control of Culex vectors that breed in pit latrines or
soakage pits[18]. These strategies for those vectors are
ready for widespread implementation. Mosquito nets
should also suppress LF transmission whenever the vec-
tors are night-biting (i.e., Anopheles, Culex, Mansonia, Ae.
vigilax), but the degree of the impact needs to be con-
firmed in controlled trials before implementation on a
country basis should be advocated.
Vector control methods for LF are more than just mos-
quito nets and polystyrene beads. Recommendations for
research and control trials were presented at a "LF
Research Forum" in 2003 [36]. Examples of priorities for
vector control research included the evaluation of insecti-
cide treated materials (including, but not limited to nets)
on Culex and source reduction on Aedes vectors.
Dengue control campaigns are now primarily based on
larval source reduction to limit transmission by the pri-
mary vector, Ae. aegypti. While important behavioural dif-
ferences exist between Ae. aegypti and  Ae. polynesiensis,
there are sufficient similarities between the two species
(both bite in the daytime and breed in containers) to
allow LF programme managers to draw some lessons from
the anti Ae. aegypti campaigns for Ae. polynesiensis control.
Integration of LF with dengue control programmes in
Aedes transmission areas makes sense. Similarly, malaria
control programmes in Anopheles  transmission areasFilaria Journal 2006, 5:10 http://www.filariajournal.com/content/5/1/10
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would also suppress LF transmission though insecticide
treated mosquito nets and/or IRS if LF elimination and
malaria control programmes were integrated.
In addition, control of the night-biting but predominantly
outdoor-feeding Mansonia vectors should include evalua-
tions of the impact on the adult populations of vegetation
removal from rivers and ponds (the larvae obtain air from
plants via a modified siphon) as well as the use of fish to
reduce the larval populations [37]. Similarly, studies to
measure reductions of Ae vigilax adults by environmental
modifications of salt marshes will be required before vec-
tor control can be advocated for extensive geographic
areas.
Before implementing a vector control strategy on a coun-
try-wide basis, the effectiveness of interventions needs to
be validated at the population level, so that limited
resources are targeted for optimal control. It is noteworthy
that China, the first country to apply for formal verifica-
tion of interruption of transmission used an integrated
control strategy that included vector control [38].
It has been argued that vector control is not cost-effective
for LF elimination. However, the cost of failing to achieve
final elimination of LF will far exceed the short-term costs
of implementing vector control for LF elimination where
it is needed.
Summary
1. MDA alone should meet the criteria for elimination of
LF in many areas, if adequate treatment coverage can be
maintained. However, it may be difficult to sustain suffi-
ciently high MDA coverage to achieve LF elimination
where Aedes spp are the vectors or where Culex popula-
tions are abundant.
2. Vector control has been effective in controlling and
even eliminating transmission of W. bancrofti either
alone or when implemented in an integrated LF pro-
gramme with MDA.
3. In addition to reducing the risk of the re-establishment
of LF, Aedes and Anopheles control for LF will reduce the
risk of dengue and malaria transmission, respectively.
4. Integration of LF with dengue and malaria control pro-
grammes where Aedes  and  Anopheles  are the vectors,
respectively, will enhance the sustainability and success of
the LF elimination efforts.
5. Vector control is the only presently available adjunct LF
control measure with the potential for immediate imple-
mentation.
6. There is still a need for larger scale trials of vector con-
trol interventions for some LF vectors.
7. However, there are vector control strategies that have
proven effective in limiting the transmission of W. ban-
crofti that can be implemented immediately, including the
use of insecticide treated mosquito nets and polystyrene
beads for control of transmission by Anopheles and Culex,
respectively.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
TRB conceived the main points presented in the manu-
script and wrote the original manuscript draft. DND and
KI provided unpublished evidence to support the main
points presented in the manuscript as well as significant
intellectual input into framing the major points pre-
sented. RS and WDM provided intellectual input into the
arguments presented.
Acknowledgements
We thank Drs David Addiss, Patrick Lammie and Robert A Wirtz for crit-
ically reviewing the manuscript.
References
1. Pichon G: Limitation and facilitation in the vectors and other
aspects of the dynamics of filarial transmission: the need for
vector control against Anopheles transmitted filariasis.  Ann
Trop Med Parasitol 2002, 96(Suppl 2):S143-S152.
2. Ichimori K, Crump A: Pacific collaboration to eliminate lym-
phatic filariasis.  Trends Parasitol 2005, 21:441-444.
3. Ottesen EA, Ismail MM, Horton J: The role of albendazole in pro-
grammes to eliminate lymphatic filariasis.  Parasitol Today 1999,
15:382-386.
4. Gyapong JO, Kumaraswami V, Biswas G, Ottesen EA: Treatment
strategies underpinning the global programme to eliminate
lymphatic filariasis.  Expert Opin Pharmacother 2005, 6:179-200.
5. Ichimori K: Entomology of the filariasis control programme in
Samoa, Aedes polynesiensis and Ae. samoanus.  Med Entomol Zool
2001, 52:11-21.
6. Esterre P, Plichart C, Sechan Y, Nguyen NL: The impact of 34
years of massive DEC chemotherapy on Wuchereria bancrofti
infection and transmission: the Maupiti cohort.  Trop Med Inter-
nat Hlth 2001, 6:190-195.
7. Laigret J, Fagneauz G, Tuira E: Chimiotherapie de masse par la
diethylcarbamazine end doses espacees: effets obtenus a
Tahiti sur la microfilaremie a Wuchereria bancrofti, var.
pacifica.  Bull World Hlth Org 1980, 58:779-783.
8. Kimura E, Penais L, Speares GF: The efficacy of annual single-
dose treatment with diethycarbamazine citrate against diur-
nally subperiodic bancroftian filariasis in Samoa.  Bull World
Hlth Org 1985, 63:1097-1106.
9. International Filariasis Review Group, Critchley J, Addiss D, Gamble
C, Garner P, Gelband H, Ejere H: Albendazole for lymphatic
filariasis.  The Cochrane Database of Systematic Reviews 2005. Art.
No.: CD003753. DOI: 10.1002/14651858.CD003753.pub3
10. Tisch AJ, Michael E, Kazura JW: Mass chemotherapy options to
control lymphatic filariasis: a systematic review.  Lancet Infect
Dis 2005, 5:514-523.
11. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Arunachalam N,
Satyanarayana K, Dash AP: Community-based study to assess
the efficacy of DEC plus ALB against DEC alone on Bancrof-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Filaria Journal 2006, 5:10 http://www.filariajournal.com/content/5/1/10
Page 7 of 7
(page number not for citation purposes)
tian filarial infection in endemic areas in Tamil Nadu, south
India.  Trop Med Internat Hlth 2006, 11:851-861.
12. Burkot TR, Taleo G, Toeaso V, Ichimori K: Initial progress
towards and challenges to filariasis elimination in Pacific
island communities.  Ann Trop Med Parasitol 2002, 96(Suppl
2):S61-69.
13. Bockarie M: Can lymphatic filariasis be eradicated in Papua
New Guinea?  Papua New Guinea Med J 1994, 37:61-64.
14. Webber RH: The natural decline of Wuchereria bancrofti infec-
tion in a vector control situation in the Solomon Islands.
Trans R Soc Trop Med Hyg 1977, 71:396-400.
15. Webber RH: Eradication of Wuchereria bancrofti infection
through vector control.  Trans R Soc Trop Med Hyg 1979,
73:722-724.
16. Boreham PFL, Marks EN: Human filariasis in Australia: Intro-
duction, investigation and elimination.  Proceedings Roy Soc
Queensland 1986, 97:23-52.
17. Sasa M: Human Filariasis Baltimore: University Park Press; 1976. 
18. Maxwell CA, Curtis CF, Haji H, Kisumku S, Thalib AI, Yahya SA: Con-
trol of Bancroftian filariasis by integrating therapy with vec-
tor control using polystyrene beads in wet pit latrines.  Trans
R Soc Trop Med Hyg 1990, 84:709-714.
19. Maxwell CA, Mohammed K, Kisumku U, Curtis CF: Can vector
control play a useful supplementary role against Bancroftian
filariasis?  Bull World Hlth Org 1999, 77:138-144.
20. Curtis CF, Malecela-Lazaro M, Reuben R, Maxwell CA: Use of float-
ing layers of polystyrene beads to control populations of the
filarial vector Culex quinquefasciatus.  Ann Trop Med Parasitol
2002, 96(Suppl 2):S97-S104.
21. Lardeux F, Riviere F, Sechan Y, Kay BH: Release of Mesocyclops
aspericornis  (Copepoda) for control of larval Aedes poly-
nesiensis (Diptera: Culicidae) in land crab burrows on an atoll
of French Polynesia.  J Med Entomol 1992, 29:571-576.
22. Laigret J, Kessel JP, Malarde L, Banbridge B, Adams H: La lutte con-
tre la filariose lympatique aperiodique en Polynesie fran-
caise.  Bull Soc pathol exotique 1965, 58:895-916.
23. Lardeux F, Sechan Y, Loncke S, Deparis X, Cheffort J, Faaruia M: Inte-
grated control of peridomestic larval habitats of Aedes and
Culex mosquitoes of French Polynesian Atolls.  J Med Entomol
2002, 39:493-498.
24. Kessel JF: An effective programme for the control of filariasis
in Tahiti.  Bull World Hlth Org 1957, 16:633-664.
25. Burnett GF: Filariasis research in Fiji, 1957-1959, parts I, II and
III.  J Trop Med Hyg 1960, 63:156-162. 181–192, 208–215
26. Dale PER, Dale PT, Hulsman K, Kay BH: Runnelling to control
saltmarsh mosquitoes: long term efficacy and environmental
impacts.  J Am Mosq Control Assoc 1993, 9:174-181.
27. Ramzy RMR, Setouhy ME, Helmy H, Ahmed ES, Elazis KMA, Farid HA,
Shannon WD, Weil GJ: Effect of yearly mass drug administra-
tion with diethylcarbamazine and albendazole on Bancroft-
ian filariasis in Egypti: a comprehensive assessment.  Lancet
2006, 365:992-999.
28. Alexander NDE, Bockarie MJ, Dimber ZB, Griffin L, Kazura JW, Alp-
ers MP: Migration and dispersal of lymphatic filariasis in
Papua New Guinea.  Trans R Soc Trop Med Hyg 2001, 95:277-279.
29. Gyapong M, Gyapong JO, Adjei S, Vlassoff C, Weiss M: Filariasis in
Northern Ghana: Some cultural beliefs and practices and
their implications for disease control.  Soc Sci Med 1996,
43:235-242.
30. Gyapong JO, Twum-Danso NAY: Global elimination of lym-
phatic filariasis: fact or fantasy?  Trop Med International Hlth 2006,
11:125-128.
31. Durrheim D, Wynd S, Liese B, Gyapong JO: Lymphatic filariasis
endemicity – an indicator of poverty?  Trop Med International Hlth
2004, 9:843-845.
32. Burkot TR, Ichimori K: The Pacific Program for the Elimination
of Lymphatic Filariasis: Will mass drug administration be
enough?  Trends Parasitol 2002, 18:109-115.
33. Taylor MJ, Makunde H, McGarry HF, Turner JD, Mand S, Hoerauf A:
Macrofilaricidal activity after doxycycline treatment of
Wuchereria bancrofti: a double-blind, randomized placebo-
controlled trial.  Lancet 2005, 365:2116-2121.
34. Bogh C, Pedersen EM, Mukoko DA, Ouma JH: Permethrin-
impregnated bednet effects on resting and feeding behav-
iour of lymphatic filariasis vector mosquitoes in Kenya.  Med
Vet Entomol 1998, 12:52-59.
35. Pedersen EM, Mukoko DA: Impact of insecticide-treated mate-
rials on filaria transmission by the various species of vector
mosquito in Africa.  Ann Trop Med Parasitol 2002, 96(Suppl
2):S91-S95.
36. Burkot T, Bockarie M: Towards a strategic plan for research to
support the Global Program to Eliminate Lymphatic Filaria-
sis. Summary of immediate needs and opportunities for
research on lymphatic filariasis. Philadelphia, Pennsylvania,
USA, December 9–10, 2003. Research directly linked with
GPELF activities (Operational Research): 2.7 Vectors.  Am J
Trop Med Hyg 2004, 96(Suppl 5:iii):24-26.
37. Rajagopalan PK, Das PK, Panicker KN, Reuben R, Rao DR, Self LS,
Lines JD: Environmental and water management for mos-
quito control.  Appropriate Technology in Vector Control 1990:121-138.
38. The Editorial Board of Control of Lymphatic Filariasis in China: Con-
trol of Lymphatic Filariasis in China.  Manila, World Health Organ-
ization Western Pacific Region 2003.
39. Lardeux F, Sechan Y, Faaruia M: Evaluation of insecticide impreg-
nated baits for control of mosquito larvae in land crab bur-
rows on French Polynesian Atolls.  J Med Entomol 2002,
39:658-661.